Stocktoria

Medpace Holdings, Inc. MEDP

Nasdaq · stock · Services-Commercial Physical & Biological Research · website · IPO 2016-08-11 · LEI

Medpace Holdings, Inc. statistics & valuation

Market cap$15.1B
P / E33.4×
P / S5.9×
P / B32.8×
P / FCF22.1×
Net margin17.8%
Return on equity98.3%
FCF margin26.9%
Return on capital84.7%
Graham number -87.8%$73.11

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($73.11); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
3.20% 9.00% 10.40% 11.70% 15.70% 15.90% 16.80% 15.00% 19.20% 17.80% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
12.50% 14.90% 14.30% 14.80% 18.00% 17.40% 19.10% 17.90% 21.20% 21.10% 2016201720182019202020212022202320242025
Return on equity (%)
2.20% 7.70% 12.20% 13.80% 18.00% 19.10% 63.50% 50.60% 49.00% 98.30% 2016201720182019202020212022202320242025
Shares outstanding
40.7M 39.8M 36.9M 37.6M 37.7M 37.7M 33.7M 31.8M 32.0M 29.5M 2016201720182019202020212022202320242025
Net debt ($)
$127.9M $178.6M $56.4M -$131.9M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
1.40% 4.10% 7.60% 8.80% 10.50% 11.00% 18.10% 17.10% 19.20% 22.80% 2016201720182019202020212022202320242025
Free cash flow margin (%)
18.50% 19.60% 19.90% 21.40% 24.60% 20.60% 24.10% 21.00% 27.10% 26.90% 2016201720182019202020212022202320242025
Debt / equity (×)
0.27× 0.40× 0.13× 0.00× 2016201720182019202020212022202320242025
EPS ($)
$0.37 $0.98 $1.97 $2.67 $3.84 $4.81 $7.28 $8.88 $12.63 $15.28 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

Medpace Holdings, Inc. trades at about 39.1× earnings — above its 10-year norm (10-year range 27.6×–94.3×, median 34.6×).

27.6× 94.3×

Shaded band = 10-year range (27.6×–94.3×); dot = today's 39.1×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin21.1%21.2%17.9%19.1%17.4%18.0%14.8%14.3%14.9%12.5%
Net margin17.8%19.2%15.0%16.8%15.9%15.7%11.7%10.4%9.0%3.2%
FCF margin26.9%27.1%21.0%24.1%20.6%24.6%21.4%19.9%19.6%18.5%
Return on assets22.8%19.2%17.1%18.1%11.0%10.5%8.8%7.6%4.1%1.4%
Return on equity98.3%49.0%50.6%63.5%19.1%18.0%13.8%12.2%7.7%2.2%
Debt / equity——————0.00×0.13×0.40×0.27×
Current ratio0.740.930.640.421.241.080.920.690.670.79

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.